Last reviewed · How we verify
Viaskin PT 25 mcg
At a glance
| Generic name | Viaskin PT 25 mcg |
|---|---|
| Sponsor | DBV Technologies |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Viaskin Pertussis Vaccine Trial (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |